Question:
Which of the following is a third generation cephalos-Porin?
Which of the following is a third generation cephalos-Porin?
Updated On: May 23, 2025
- Cefotaxime
- Cefuroxime
- Cefazoline
- Cefeprime
Hide Solution
Verified By Collegedunia
The Correct Option is A
Solution and Explanation
The correct option is (A): Cefotaxime
Was this answer helpful?
0
0
Top Questions on Different classes of therapeutic drugs
- Match the following disease with their test for detection:
Disease Diagnostic tests P. Tuberculosis (i) Lepromin test Q. AIDS (ii) ELISA R. Syphilis (iii) Mantoux test S. Leprosy (iv) Kahn's test - GPAT - 2024
- Pharmaceutical Chemistry
- Different classes of therapeutic drugs
- Tetracycline undergoes epimerization at C4 between pH 4-8 to give:
- GPAT - 2024
- Pharmaceutical Chemistry
- Different classes of therapeutic drugs
- 5-Fluorouracil, an anti-metabolite used in cancer treatment, is activated to:
- GPAT - 2024
- Pharmaceutical Chemistry
- Different classes of therapeutic drugs
- Match the following antibodies with their correct description:
Antibody Description P. IgE (i) Cross the placenta Q. IgG (ii) Dominant antibody produced in immune responses R. IgM (iii) It is found in the mother's milk S. IgA (iv) Responsible for autoimmune responses including allergies - GPAT - 2024
- Pharmaceutical Chemistry
- Different classes of therapeutic drugs
- Tetracycline undergoes epimerization at C4 between pH 4-8 to give:
- GPAT - 2024
- Pharmaceutical Chemistry
- Different classes of therapeutic drugs
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions